Pharmalot… Pharmalittle… The Morning After
Make a commentBy Ed Silverman // November 5th, 2008 // 6:49 am
And so a long and dramatic election season has come to an end. Now, we can look ahead to the possibilities and challenges. While you contemplate, here are a few items to digest as we tend to the short people and boil our usual steaming hot cup of stimulation…
Genzyme Inks $1.4M Development Deal With Osiris (Bloomberg News)
UK’s NHS Relaxes Rules On Drug Fees (The Financial Times)
Medco Health Quarterly Profit Rises (MarketWatch)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Genzyme, Medco Health Solutions, National Health Service, Osiris Therapeutics, UK